|
GLIS3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.18749454713907E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.28850280340021E-11 |
| Normal-vs-Stage2 |
1.24729999662065E-08 |
| Normal-vs-Stage3 |
2.23343565863843E-12 |
| Normal-vs-Stage4 |
4.10782519111308E-14 |
| Stage1-vs-Stage2 |
2.503600E-01 |
| Stage1-vs-Stage3 |
1.093350E-01 |
| Stage1-vs-Stage4 |
8.44309999999959E-05 |
| Stage2-vs-Stage3 |
5.201900E-02 |
| Stage2-vs-Stage4 |
1.395450E-03 |
| Stage3-vs-Stage4 |
4.826400E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.76334552199387E-12 |
| Normal-vs-AfricanAmerican |
4.05510000023313E-07 |
| Normal-vs-Asian |
2.19835261106027E-12 |
| Caucasian-vs-AfricanAmerican |
1.016430E-01 |
| Caucasian-vs-Asian |
1.138210E-01 |
| AfricanAmerican-vs-Asian |
3.250100E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.14890327754347E-11 |
| Normal-vs-Female |
1.04649622301167E-11 |
| Male-vs-Female |
9.052600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.82716122418969E-12 |
| Normal-vs-Age(41-60Yrs) |
2.44979592167738E-11 |
| Normal-vs-Age(61-80Yrs) |
2.39549491354296E-11 |
| Normal-vs-Age(81-100Yrs) |
3.459000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.230000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.326800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.894000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.774800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.597600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.301000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.84379999999385E-05 |
| Classical-VS-Follicular |
1.868040E-02 |
| Classical-VS-Other |
5.494600E-01 |
| Classical-VS-Normal |
1.73130398906096E-11 |
| Tall-VS-Follicular |
3.6093999999931E-06 |
| Tall-VS-Other |
2.971200E-01 |
| Tall-VS-Normal |
4.46309655899313E-14 |
| Follicular-VS-Other |
6.377800E-02 |
| Follicular-VS-Normal |
2.49639999783113E-08 |
| Other-VS-Normal |
9.92440000180395E-08 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.68090019470446E-11 |
| Normal-vs-N1 |
1.73017156157584E-12 |
| N0-vs-N1 |
7.958100E-04 |
|
|
